Sign in

CIK 0001357459 · Non-accelerated filer<br>Smaller reporting company

PALISADE BIO, INC.

Sign in to watch
Ticker
PALI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
522007292
Phone
(858) 704-4900
Business address
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
Former names
PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market buy Chief Financial Officer bought 19,481.24 shares at $0.14 ($2,799)
  4. 4 Open-market buy Chief Financial Officer bought 7,350 shares at $0.16 ($1,176)
  5. 4 Open-market buy Chief Executive Officer bought 40,000 shares at $0.25 ($10,000)
  6. 4 Open-market buy Chief Financial Officer bought 100,000 shares at $0.25 ($25,000)
  7. 4 Other acquisition Chief Financial Officer acquired 12,545 shares (other)
  8. 4 Open-market buy Chief Medical Officer bought 15,000 shares at $1.14 ($17,093)
  9. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $1.18 ($11,800)
  10. 4 Open-market buy Chief Financial Officer bought 7,500 shares at $1.09 ($8,174)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 6 of 18 · 343 filings